The FDA has granted traditional approval to Rubraca (rucaparib) for metastatic castration-resistant prostate cancer.
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...
Italy closes probe into DeepSeek after commitments to warn of AI 'hallucination' risks Italy’s antitrust authority has ended an investigation into the Chinese AI system DeepSeek for allegedly failing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback